Breast ImagingPreliminary study: Breast cancers can be well seen on 3T breast MRI with a half-dose of Gadobutrol (cas 138071-82-6)

Add time:08/17/2019    Source:sciencedirect.com

BackgroundDynamic contrast enhanced (DCE) breast MRI is highly sensitive for breast cancer and requires gadolinium-based contrast agents (GBCA)s, which have potential safety concerns.

We also recommend Trading Suppliers and Manufacturers of Gadobutrol (cas 138071-82-6). Pls Click Website Link as below: cas 138071-82-6 suppliers

Prev:Gadobutrol (cas 138071-82-6) enhances T1-weighted MRI of nerve cells
Next:One-pot synthesis of 4,4-difluoro-3-oxo-2-(triphenylphosphoranylidene)-δ-lactones by Reformatsky reaction)